BamSEC and AlphaSense Join Forces
Learn More

Bio Green Med Solution, Inc. – Indentures

NASDAQ: BGMS    
Share price (7/14/26): $0.91    
Market cap (7/14/26): $4.995 million

Indentures Filter

EX-4.12
from 10-K 11 pages Description of the Registrant’s Securities
12/34/56
EX-4.12
from 10-K/A 13 pages Description of Securities
12/34/56
EX-4.12
from 10-K 14 pages Description of Securities
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.3
from 8-K 20 pages Placement Agent Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc. Warrant Shares: Issue Date: November 14, 2024
12/34/56
EX-4.2
from 8-K 21 pages Series D Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc. Warrant Shares: Issue Date: , 2024
12/34/56
EX-4.1
from 8-K 21 pages Series C Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc. Warrant Shares: Issue Date: , 2024
12/34/56
EX-4.4
from 8-K 18 pages Placement Agent Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.3
from 8-K 18 pages Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.2
from 8-K 17 pages Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.13
from S-1/A 20 pages Pre-Funded Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.12
from S-1/A 27 pages Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.12
from 10-K 13 pages Description of Securities
12/34/56
EX-4.2
from 8-K 19 pages Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-4.10
from 10-K/A 12 pages Description of Securities
12/34/56
EX-4.13
from S-3 52 pages Cyclacel Pharmaceuticals, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.12
from S-3 52 pages Cyclacel Pharmaceuticals, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.10
from 10-K 12 pages Description of Securities
12/34/56